BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37903649)

  • 1. Differential diagnosis of small hepatocellular nodules in cirrhosis: surrogate histological criteria of TERT promoter mutations.
    Beaufrère A; Paisley S; Ba I; Laouirem S; Priori V; Cazier H; Favre L; Cauchy F; Lesurtel M; Calderaro J; Kannengiesser C; Paradis V
    Histopathology; 2024 Feb; 84(3):473-481. PubMed ID: 37903649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis.
    Nault JC; Calderaro J; Di Tommaso L; Balabaud C; Zafrani ES; Bioulac-Sage P; Roncalli M; Zucman-Rossi J
    Hepatology; 2014 Dec; 60(6):1983-92. PubMed ID: 25123086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the prognosis of advanced hepatocellular carcinoma by TERT promoter mutations in circulating tumor DNA.
    Hirai M; Kinugasa H; Nouso K; Yamamoto S; Terasawa H; Onishi Y; Oyama A; Adachi T; Wada N; Sakata M; Yasunaka T; Onishi H; Shiraha H; Takaki A; Okada H
    J Gastroenterol Hepatol; 2021 Apr; 36(4):1118-1125. PubMed ID: 32830343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.
    Quaglia A; Jutand MA; Dhillon A; Godfrey A; Togni R; Bioulac-Sage P; Balabaud C; Winnock M; Dhillon AP
    World J Gastroenterol; 2005 Oct; 11(40):6262-8. PubMed ID: 16419153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of genetic aberrations linked to tumorigenesis in regenerative nodules of liver cirrhosis.
    Kim SK; Takeda H; Takai A; Matsumoto T; Kakiuchi N; Yokoyama A; Yoshida K; Kaido T; Uemoto S; Minamiguchi S; Haga H; Shiraishi Y; Miyano S; Seno H; Ogawa S; Marusawa H
    J Gastroenterol; 2019 Jul; 54(7):628-640. PubMed ID: 30756187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.
    Libbrecht L; Severi T; Cassiman D; Vander Borght S; Pirenne J; Nevens F; Verslype C; van Pelt J; Roskams T
    Am J Surg Pathol; 2006 Nov; 30(11):1405-11. PubMed ID: 17063081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies.
    Maggioni M; Coggi G; Cassani B; Bianchi P; Romagnoli S; Mandelli A; Borzio M; Colombo P; Roncalli M
    Hepatology; 2000 Nov; 32(5):942-6. PubMed ID: 11050043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular nodules in cirrhosis: focus on diagnostic criteria on liver biopsy. A Western experience.
    Roncalli M
    Liver Transpl; 2004 Feb; 10(2 Suppl 1):S9-15. PubMed ID: 14762832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trunk mutational events present minimal intra- and inter-tumoral heterogeneity in hepatocellular carcinoma.
    Torrecilla S; Sia D; Harrington AN; Zhang Z; Cabellos L; Cornella H; Moeini A; Camprecios G; Leow WQ; Fiel MI; Hao K; Bassaganyas L; Mahajan M; Thung SN; Villanueva A; Florman S; Schwartz ME; Llovet JM
    J Hepatol; 2017 Dec; 67(6):1222-1231. PubMed ID: 28843658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules.
    Mokrane FZ; Lu L; Vavasseur A; Otal P; Peron JM; Luk L; Yang H; Ammari S; Saenger Y; Rousseau H; Zhao B; Schwartz LH; Dercle L
    Eur Radiol; 2020 Jan; 30(1):558-570. PubMed ID: 31444598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular dysplastic nodules.
    Roncalli M; Borzio M; Di Tommaso L
    Ann Ital Chir; 2008; 79(2):81-9. PubMed ID: 18727269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver disease.
    Nakanuma Y; Hirata K; Terasaki S; Ueda K; Matsui O
    Histol Histopathol; 1998 Oct; 13(4):1077-87. PubMed ID: 9810504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.
    Kim MJ; Lee S; An C
    Eur Radiol; 2019 Sep; 29(9):5101-5110. PubMed ID: 30788586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA Methylation Profiling of Human Hepatocarcinogenesis.
    Hernandez-Meza G; von Felden J; Gonzalez-Kozlova EE; Garcia-Lezana T; Peix J; Portela A; Craig AJ; Sayols S; Schwartz M; Losic B; Mazzaferro V; Esteller M; Llovet JM; Villanueva A
    Hepatology; 2021 Jul; 74(1):183-199. PubMed ID: 33237575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase reverse transcriptase promoter mutations in hepatitis B virus-associated hepatocellular carcinoma.
    Yang X; Guo X; Chen Y; Chen G; Ma Y; Huang K; Zhang Y; Zhao Q; Winkler CA; An P; Lyu J
    Oncotarget; 2016 May; 7(19):27838-47. PubMed ID: 27056898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RESULTS OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA AND NODULES WITH HIGH-GRADE DYSPLASIA IN PATIENTS WITH CIRRHOSIS.
    Coral GP; Branco F; Meurer R; Marcon PDS; Fontes PRO; Mattos AA
    Arq Gastroenterol; 2021; 58(1):82-86. PubMed ID: 33909802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm.
    Renzulli M; Biselli M; Brocchi S; Granito A; Vasuri F; Tovoli F; Sessagesimi E; Piscaglia F; D'Errico A; Bolondi L; Golfieri R
    Gut; 2018 Sep; 67(9):1674-1682. PubMed ID: 29437912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination of cirrhotic nodules, dysplastic lesions and hepatocellular carcinoma by their vibrational signature.
    Peng C; Kaščáková S; Chiappini F; Olaya N; Sandt C; Yousef I; Samuel D; Dumas P; Guettier C; Le Naour F
    J Transl Med; 2016 Jan; 14():9. PubMed ID: 26754490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.